* Dyadic International Inc DYAI.OQ reported a quarterly
adjusted
loss of 8 cents per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of -7 cents. The mean expectation of two analysts for the
quarter was for a loss of 6 cents per share. Wall Street
expected results to range from -8 cents to -5 cents per share.
* Revenue fell 7.7% to $687.00 thousand from a year ago;
analysts
expected $800.00 thousand.
* Dyadic International Inc's reported EPS for the quarter
was a
loss of 8 cents.
* The company reported a quarterly loss of $2.04 million.
* Dyadic International Inc shares had risen by 1.2% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Dyadic
International Inc is $7.50
This summary was machine generated from LSEG data March 28 at
09:02 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.06 -0.08 Missed
Sep. 30 2023 -0.06 -0.06 Met
Jun. 30 2023 -0.05 -0.07 Missed